Saturday 17 October 2026
Export BDSX’s income statement to Excel — free account
Biodesix, Inc.
BDSX Healthcare Diagnostics & Research
Biodesix, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $88.5 million, up 24.1% from fiscal 2024. In the quarter to June 2026, revenue grew 34.2%, EPS grew 55.6%, free cash flow grew 72.8% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
23.66
1.05
−4.25%
Follow BDSX
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | — | 4 | 3 | 3 | 4 | 4 | 4 |
P/S ratio |
— | 0.13 | 0.13 | 2.14 | 2.66 | 2.26 | 2.98 | 2.78 | 0.58 |
Altman Z-Score |
— | — | — | (1.97) | (4.84) | (5.72) | (5.77) | (5.23) | (7.46) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (25.92) | (22.77) | (4.77) | (14.92) | (14.10) | (16.14) | (15.90) | (19.59) |
P/Operating CF |
— | (0.94) | (0.94) | (11.14) | (14.20) | (7.22) | (11.90) | (48.34) | 66.00 |
Beneish M-Score |
— | — | (2.17) | (1.35) | (3.80) | (3.19) | (3.50) | (1.92) | (3.13) |
P/B ratio |
— | 0.00 | 0.00 | 2.37 | 7.34 | 4.19 | 31.91 | 9.48 | 0.00 |
Price to Tangible BV |
— | 0.00 | 0.00 | 7.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 1.92 | 1.92 | 1.39 | 2.24 | 1.79 | 3.16 | 2.92 | 0.90 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (2.80) | (2.80) | (2.96) | (4.33) | (1.52) | (6.78) | (4.28) | (3.43) |
EV/FCF |
— | (2.50) | (2.50) | (2.68) | (3.97) | (1.41) | (3.38) | (4.00) | (3.37) |
Quick Ratio |
— | 1.79 | 0.47 | 2.41 | 1.26 | 2.11 | 1.02 | 2.43 | 1.61 |
Current Ratio |
— | 2.22 | 0.56 | 2.68 | 1.51 | 2.34 | 1.19 | 2.76 | 1.87 |
Net Debt/EBITDA |
— | (1.04) | (1.30) | 2.42 | 0.65 | 0.46 | (0.29) | (0.39) | (1.36) |
Debt/Assets |
0.00% | 59.14% | 79.88% | 22.93% | 13.16% | 26.97% | 35.60% | 37.46% | 54.24% |
Debt/Equity |
— | (0.12) | (0.16) | 0.67 | 0.51 | 1.22 | 7.70 | 1.75 | (19.25) |
Asset Turnover |
— | 1.05 | 0.58 | 0.55 | 0.55 | 0.45 | 0.51 | 0.73 | 0.96 |
Operating CF/Net income |
— | 0.68 | 0.71 | 0.68 | 0.65 | 0.69 | 0.44 | 1.13 | 0.66 |
Capex/Depreciation |
— | 0.00 | (0.44) | (0.25) | (0.43) | (0.32) | (2.16) | (0.42) | (0.06) |
Interest Coverage |
— | (12.29) | (8.89) | (3.02) | (9.08) | (6.27) | (4.34) | (4.18) | (3.61) |
| — | 12.37% | 14.52% | 34.08% | (141.75%) | (324.53%) | (414.09%) | (337.30%) | (383.09%) | |
| — | (133.99%) | (73.08%) | (37.75%) | (43.78%) | (77.45%) | (54.32%) | (43.73%) | (38.18%) | |
ROIC |
— | 0.00% | 0.00% | (210.60%) | 0.00% | (1,229.75%) | (190.38%) | (69.42%) | (67.00%) |
Return on Tangible Assets |
— | (382.94%) | 394.94% | (54.81%) | (229.18%) | (180.08%) | (152.77%) | (81.01%) | (88.39%) |
Average Days of Receivables |
— | 33.80 | 78.67 | 122.61 | 24.48 | 48.38 | 57.10 | 44.03 | 37.27 |
Research and Development Expense of Revenue |
— | 40.07% | 42.64% | 23.75% | 23.46% | 34.29% | 20.35% | 13.40% | 13.56% |
Selling, General and Administrative Expense of Revenue |
— | 126.76% | 124.78% | 76.51% | 92.68% | 160.84% | 137.28% | 112.80% | 98.92% |
Intangible Assets out of Total Assets |
0.00 | 0.71 | 0.67 | 0.23 | 0.35 | 0.27 | 0.23 | 0.22 | 0.22 |
Share Based Compensation of Revenue |
— | 0.00% | 0.69% | 8.14% | 9.07% | 15.60% | 10.95% | 9.31% | 4.68% |
Graham Net Nets |
— | (79.63) | (79.63) | 0.06 | (0.09) | (0.22) | (0.38) | (0.19) | (1.12) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.97 |
Earnings Yield |
— | (774.27%) | (774.27%) | (493.17%) | (29.68%) | (77.56%) | (36.52%) | (22.88%) | (71.32%) |
Free Cash Flow Yield |
— | (577.14%) | (577.14%) | (24.14%) | (21.25%) | (56.20%) | (31.45%) | (26.31%) | (46.11%) |
Revenue per Share |
— | 0.77 | 2,029.09 | 188.33 | 39.83 | 18.15 | 11.96 | 11.02 | 11.72 |
Operating CF per Share |
— | (0.67) | (1,795.54) | (88.33) | (20.63) | (21.36) | (5.57) | (7.52) | (3.08) |
Capex per Share |
— | 0.00 | (117.02) | (9.00) | (1.86) | (1.68) | (5.62) | (0.53) | (0.05) |
Free Cash Flow per Share |
— | (0.67) | (1,912.56) | (97.33) | (22.49) | (23.04) | (11.19) | (8.05) | (3.14) |
Cash per Share |
— | 0.23 | 436.86 | 256.83 | 23.91 | 20.47 | 6.40 | 4.06 | 2.51 |
Shareholders Equity per Share |
— | (7.46) | (18,606.53) | 170.18 | 14.42 | 9.79 | 1.12 | 3.23 | (0.33) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (7.46) | (18,606.53) | 170.18 | 14.42 | 9.79 | 1.12 | 3.23 | (0.33) |
Free Cash Flow |
— | (17.68) | (23.14) | (23.54) | (30.77) | (48.51) | (45.93) | (52.09) | (23.67) |
Working Capital |
— | 5.45 | (9.90) | 54.02 | 14.65 | 30.50 | 6.27 | 25.17 | 15.08 |
Capital Expenditures |
— | (0.62) | (1.42) | (2.18) | (2.55) | (3.53) | (23.06) | (3.44) | (0.40) |
Net Current Asset Value |
— | (43.21) | (257.47) | 6.24 | (12.76) | (18.97) | (54.83) | (36.88) | (57.42) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.06 | 0.05 | 0.05 | 0.09 | 0.47 | 0.05 | 0.00 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 1.25 | 1.51 | 2.74 | 1.41 | 1.87 | 0.38 | 0.29 | 0.28 |
Cash ROIC |
— | 10.47% | 12.59% | (17.96%) | (49.27%) | (54.66%) | (69.45%) | (62.34%) | (37.01%) |
Accounts Receivable Turnover |
— | 5.69 | 6.84 | 4.42 | 5.75 | 8.76 | 7.70 | 8.76 | 10.03 |
Accounts Payable Turnover |
— | 3.39 | 4.67 | 4.12 | 5.74 | 8.46 | 5.64 | 6.08 | 6.34 |
Inventory Turnover |
— | 5.87 | 8.10 | 11.00 | 10.01 | 6.58 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 73.40 | 103.18 | 148.73 | 19.88 | 43.45 | 82.17 | 51.42 | 67.24 |
Days of Inventory on Hand |
— | 57.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 3.59 | 3.59 | 10.30 | 9.48 | 4.36 | 6.37 | 8.14 | 8.82 |
Average Payables |
— | 1.30 | 1.30 | 5.34 | 5.31 | 1.67 | 2.31 | 2.56 | 2.64 |
Average Inventory |
— | 0.75 | 0.75 | 2.00 | 3.05 | 2.15 | — | — | — |
Average Assets |
— | 19.53 | 42.05 | 83.05 | 98.58 | 84.50 | 96.00 | 98.17 | 92.36 |
Average Common Equity |
— | (211.58) | (211.58) | (91.99) | 30.45 | 20.17 | 12.59 | 12.73 | 9.21 |
Columns are period end dates